Clostridium Difficile - part 3

Peripheral eosinopenia upon admission serves as a significant predictor for adverse outcomes in *Clostridium Difficile* patients, including increased mortality and the necessity for colectomy. Avoiding beta-lactam antibiotics due to documented penicillin allergies—which are frequently misdiagnosed—correlates with a 55% increased risk of MRSA and a 35% increased risk of *C. diff*. Fecal microbiota transplantation, particularly via oral capsules, offers superior efficacy in preventing recurrence compared to standard antibiotic courses, while bezlotoxumab provides a monoclonal antibody option to neutralize toxin B. Diagnostic algorithms remain complex, requiring a combination of clinical assessment and laboratory testing, as no single test currently provides both high sensitivity and specificity. Elevated creatinine, lactate levels, and imaging evidence of toxic megacolon further signal high-risk cases, necessitating urgent clinical intervention.